Reclaimed water fishery: Huanong assets plans to increase its holding of 1% - 2% of the company's shares
According to the announcement of reclaimed water fishery, the concerted action of the actual controller, Renhua agricultural assets plans to increase its holding of 1% - 2% of the company's shares.
This text is a result of machine translation.
Related companies：
Briefing Jun 09, 2022 08:44 AM
· Technology
CITIC Securities: the development of the information innovation industry continues to deepen, with an annual scale of over 20/40 billion and is expected to speed up gradually
In-depth
Briefing Jun 08, 2022 08:23 PM
· Technology
Atlas solar response and Solaria patent dispute settlement
Briefing Jan 25, 2022 04:30 PM
· Technology
Wal nuclear material: the holding subsidiary is recognized as a high-tech enterprise
Jan 30, 2026 06:00 PM
Aug 11, 2025 06:22 PM
Dec 11, 2023 08:49 PM
Nov 16, 2022 05:19 PM
Briefing Dec 09, 2021 01:09 PM
· Technology
Digital productivity service provider "Rongzhi information" completes a new round of strategic financing
Briefing Oct 15, 2021 06:20 PM
· Technology
UFIDA network: some directors, supervisors and senior managers plan to reduce their holdings of no more than 0.0454% of the company's shares in total
Briefing Sep 28, 2021 06:10 PM
Hangzhou hi tech: Director Zhou Jianhua completed the increase of 1007800 shares
Healthcare
Mabwell Signs GCC Licensing Deal with Saudi Arabia’s SVAX for Aflibercept Biosimilar
Mabwell (Shanghai) Bioscience Co., Ltd.（迈威（上海）生物科技股份有限公司）has entered into a licensing agreement with Saudi Arabian biopharmaceutical company SVAX Inc. covering its aflibercept biosimilar, 9MW0813, in the Gulf Cooperation Council market.
Yesterday 03:00 PM
Healthcare
Insilico Medicine (英矽智能) Signs Strategic Drug Discovery Partnership with Takeda (武田制药), Deal Worth Up to US$600 Million
Chinese AI drug discovery company Insilico Medicine (英矽智能) has signed a global strategic collaboration with Japanese pharmaceutical company Takeda (武田制药), with the total potential deal value reaching up to US$600 million. Announced in early July, the agreement marks another milestone in the international commercialization of China's AI-powered drug discovery technologies through collaboration with a leading multinational pharmaceutical company.
Jul 16, 2026 02:33 PM
Briefing Sep 15, 2021 04:56 PM
Italy Mattioli family's strategic investment in manfuli China is 10 million euros
Briefing Sep 06, 2021 06:49 PM
· Automotive
Chujiang Xincai: recently received a total of 27.5481 million yuan of government subsidies related to income
Briefing Aug 20, 2021 07:13 PM
UFIDA network: it has applied to the CSRC for resumption of examination of non-public offering of shares
Briefing Aug 20, 2021 04:50 PM
· Technology
Zhenghai magnetic materials: Zhao Juntao, director and deputy general manager, completed the reduction of 350000 shares
Briefing Aug 02, 2021 03:56 PM
Shuangjian shares: the application for issuing convertible bonds was approved by the CSRC
See more
Read next
Insight
In-depth
Low-altitude Economy · Interview
A Small Aircraft, a Bigger Bet: How China's Worthy Aero Plans to Scale Up
Yesterday 02:44 PM
Insight
In-depth
Consumer Staples · Analysis
EqualOcean Releases 2026 Chinese GoGlobal Physical Retail Brands Top 10 at GGF2026
Jun 17, 2026 02:50 PM